Olema Pharmaceuticals (OLMA) Current Assets (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Current Assets data on file, last reported at $513.2 million in Q1 2026.

• Current Assets for Q1 2026 came in at $513.2 million, up 29.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $513.2 million (up 29.39% YoY), and the FY2025 annual result was $515.5 million, up 17.56% from the prior year.
• Current Assets steadied at $513.2 million in Q1 2026 per OLMA's latest filing, from $515.5 million in the prior quarter.
• Over five years, Current Assets peaked at $515.5 million in Q4 2025 and troughed at $171.5 million in Q2 2023.
• A 5-year average of $302.0 million and a median of $266.5 million in 2023 frame the typical range for Current Assets.
• The sharpest annual moves came in 2023 and 2024: Current Assets decreased 29.91% in 2023, then jumped 64.52% in 2024.
• A 5-year view of Current Assets shows it stood at $208.9 million in 2022, then increased by 27.58% to $266.5 million in 2023, then jumped by 64.52% to $438.5 million in 2024, then rose by 17.56% to $515.5 million in 2025, then decreased by 0.43% to $513.2 million in 2026.
• Business Quant data shows OLMA's Current Assets at $513.2 million in Q1 2026, $515.5 million in Q4 2025, and $334.3 million in Q3 2025.